APRINOIA Therapeutics is a series unknown startup based in United States. 1 investor tracked.
APRINOIA Therapeutics is a startup based in the United States. Its most recent tracked round is Series-unknown. Brouky records 1 investor associated with the company.
APRINOIA Therapeutics develops diagnostic tools and targeted therapeutics for neurodegenerative diseases by focusing on protein aggregates such as tau and alpha-synuclein, which are critical in conditions like Alzheimer’s and Parkinson’s diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.